TRANSURETHRAL BLADDER BIOPSY AFTER POST INTRAVESICAL BCG THERAPY FOR SUPERFICIAL BLADDER CANCER PATIENTS

Telomerase Reverse Transcriptase and miR-34a in diagnosis of non-muscle invasive bladder cancer

Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

Using of Telomerase Enzyme in Urine as a Non invasive Marker for Cancer Bladder Detection

Enhancement of Urinary Bladder Carcinogenesis by the Role of Chronic Bacterial Infection-induced Inflammation (Imunnohistochemical and Biochemical studies)

VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

Role of Urine Cytology in Accurate Diagnosis of Urothelial Carcinoma: An Immunohistochemical Study

Evaluation of IGF-2 Gene Expression in Urine and its Potential Use as Biomarker for Bladder Cancer

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression